首页> 外文期刊>Endoscopy: Journal for Clinical Use Biopsy and Technique >Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2.
【24h】

Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2.

机译:使用第二代胶囊内窥镜检查检测食道疾病:PillCam ESO 2的初步评估。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND STUDY AIM: Esophageal capsule endoscopy (ECE) provides an alternative, minimally invasive modality for evaluating the esophagus. This study evaluates the performance and test characteristics of a second-generation esophageal capsule endoscope, the PillCam ESO 2. METHODS: Adults with known or suspected esophageal disease were included. Using the simplified ingestion procedure, each patient underwent capsule endoscopy with the PillCam ESO 2. Following ECE, esophagogastroduodenoscopy (EGD) was performed on the same day by an investigator who was blinded to the results of the ECE. In random order, capsule endoscopy videos were read and interpreted by the study investigator blinded to EGD results. RESULTS: 28 patients (19 men, 9 women; mean age 53.3 years) were included. In 82 % of the patients, at least 75 % of the Z line was visualized by the PillCam ESO 2. A per-lesion analysis demonstrated that the PillCam ESO 2 had definitive results in 30/43 lesions (69.8 %) and EGD in 29/43 (67.4 %), Pvalue = 0.41. Compared with EGD for detecting suspected Barrett's esophagus and esophagitis, the PillCam ESO 2 had a sensitivity of 100 % and a specificity of 74 %, and a sensitivity of 80 % and a specificity of 87 %, respectively. The PillCam ESO 2 demonstrated 86 % agreement with EGD in describing the Z line (kappa statistic 0.68). The modified ingestion protocol provided excellent cleansing, with bubbles/saliva having no or only a minor effect on Z line images in 86 % of cases. CONCLUSIONS: The PillCam ESO 2 demonstrated excellent visualization of the Z line. Compared with standard EGD, the PillCam ESO 2 had good test characteristics with high rates of detection of suspected Barrett's esophagus and esophagitis. This study provides indirect validation of the simplified ingestion procedure. The PillCam ESO 2 acquires high quality esophageal images, performs safely, and should be able to replace the current PillCam ESO.
机译:背景与研究目的:食管胶囊内镜检查(ECE)为评估食管提供了另一种微创方法。这项研究评估了第二代食道胶囊内窥镜PillCam ESO 2的性能和测试特性。方法:包括已知或怀疑食道疾病的成人。使用简化的摄入程序,每位患者均使用PillCam ESO 2进行了胶囊内镜检查。在进行ECE手术后,调查人员于同一天进行了食管胃十二指肠镜检查(EGD),该研究人员对ECE的结果视而不见。对研究人员不了解EGD结果的情况,以随机顺序读取和解释了胶囊内窥镜检查视频。结果:包括28例患者(男19例,女9例;平均年龄53.3岁)。在PillCam ESO 2中,在82%的患者中,至少有75%的Z线可视化。每个病灶分析表明,PillCam ESO 2在30/43个病变(69.8%)和29个EGD中具有确定的结果/ 43(67.4%),Pvalue = 0.41。与EGD检测可疑的Barrett食道和食道炎相比,PillCam ESO 2的敏感度为100%,特异性为74%,敏感度为80%,特异性为87%。在描述Z线时,PillCam ESO 2与EGD表现出86%的一致性(kappa统计量为0.68)。改良的摄入方案可提供出色的清洁效果,在86%的病例中,气泡/唾液对Z线图像没有影响或仅有很小的影响。结论:PillCam ESO 2展示了Z线的出色可视化效果。与标准EGD相比,PillCam ESO 2具有良好的测试特性,并且可疑巴雷特食管和食道炎的检出率很高。这项研究提供了简化摄入程序的间接验证。 PillCam ESO 2可获取高质量的食道图像,操作安全,并且应该能够替代当前的PillCam ESO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号